Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research

Abstract There is emerging evidence that microRNAs (miRNAs) dysregulation is involved in the genesis and the progression of Prostate Cancer (PCa), thus potentially increasing their use in urological clinical practice. This is the first pilot study which utilizes Illumina Deep Sequencing to examine t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gabriella Guelfi, Giovanni Cochetti, Valentina Stefanetti, Danilo Zampini, Silvana Diverio, Andrea Boni, Ettore Mearini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ed8ff32997bd4cbd83124e080b3d91c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ed8ff32997bd4cbd83124e080b3d91c3
record_format dspace
spelling oai:doaj.org-article:ed8ff32997bd4cbd83124e080b3d91c32021-12-02T16:08:13ZNext Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research10.1038/s41598-018-24236-y2045-2322https://doaj.org/article/ed8ff32997bd4cbd83124e080b3d91c32018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-24236-yhttps://doaj.org/toc/2045-2322Abstract There is emerging evidence that microRNAs (miRNAs) dysregulation is involved in the genesis and the progression of Prostate Cancer (PCa), thus potentially increasing their use in urological clinical practice. This is the first pilot study which utilizes Illumina Deep Sequencing to examine the entire miRNAs spectrum existent in urine exfoliated prostate cells (UEPCs) of PCa patients. A total of 11 male patients with histological diagnosis of PCa were enrolled in the present study. First-catch urine (30 mL) was collected following a prostate massage. Total RNA was extracted from urine and sequenced using an HiSeq2500 System (Illumina). QPCR assay was used to validate the highest NGS results in PCA patients and in age-matched, caucasian men. Remarkably, PCA let-7 family was down-regulated (P < 0.01), compared to the controls. The results of our study support the notion of a relatively high diagnostic value of miRNA family for PCa detection, especially in the let-7 family. The present research confirmed the potential use of miRNAs as non-invasive biomarkers in the diagnosis of PCa, potentially reducing the invasiveness of actual clinical strategy.Gabriella GuelfiGiovanni CochettiValentina StefanettiDanilo ZampiniSilvana DiverioAndrea BoniEttore MeariniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gabriella Guelfi
Giovanni Cochetti
Valentina Stefanetti
Danilo Zampini
Silvana Diverio
Andrea Boni
Ettore Mearini
Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
description Abstract There is emerging evidence that microRNAs (miRNAs) dysregulation is involved in the genesis and the progression of Prostate Cancer (PCa), thus potentially increasing their use in urological clinical practice. This is the first pilot study which utilizes Illumina Deep Sequencing to examine the entire miRNAs spectrum existent in urine exfoliated prostate cells (UEPCs) of PCa patients. A total of 11 male patients with histological diagnosis of PCa were enrolled in the present study. First-catch urine (30 mL) was collected following a prostate massage. Total RNA was extracted from urine and sequenced using an HiSeq2500 System (Illumina). QPCR assay was used to validate the highest NGS results in PCA patients and in age-matched, caucasian men. Remarkably, PCA let-7 family was down-regulated (P < 0.01), compared to the controls. The results of our study support the notion of a relatively high diagnostic value of miRNA family for PCa detection, especially in the let-7 family. The present research confirmed the potential use of miRNAs as non-invasive biomarkers in the diagnosis of PCa, potentially reducing the invasiveness of actual clinical strategy.
format article
author Gabriella Guelfi
Giovanni Cochetti
Valentina Stefanetti
Danilo Zampini
Silvana Diverio
Andrea Boni
Ettore Mearini
author_facet Gabriella Guelfi
Giovanni Cochetti
Valentina Stefanetti
Danilo Zampini
Silvana Diverio
Andrea Boni
Ettore Mearini
author_sort Gabriella Guelfi
title Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
title_short Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
title_full Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
title_fullStr Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
title_full_unstemmed Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
title_sort next generation sequencing of urine exfoliated cells: an approach of prostate cancer micrornas research
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/ed8ff32997bd4cbd83124e080b3d91c3
work_keys_str_mv AT gabriellaguelfi nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT giovannicochetti nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT valentinastefanetti nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT danilozampini nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT silvanadiverio nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT andreaboni nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
AT ettoremearini nextgenerationsequencingofurineexfoliatedcellsanapproachofprostatecancermicrornasresearch
_version_ 1718384568733532160